Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight
Author(s) -
Meghna Desai,
Julie Gutman,
Steve M. Taylor,
Ryan E. Wiegand,
Carole Khairallah,
Kassoum Kayentao,
Peter Ouma,
Sheick Oumar Coulibaly,
Linda Kalilani,
Kimberly E. Mace,
Emmanuel Arinaitwe,
Don P. Mathanga,
Ogobara K. Doumbo,
Kephas Otieno,
Edgar Dabira,
Ebbie Chaluluka,
Mulakwa Kamuliwo,
Veronica Ades,
Jacek Skarbinski,
Ya Ping Shi,
Pascal Magnussen,
Steve Meshnick,
Feiko O. ter Kuile
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ881
Subject(s) - medicine , sulfadoxine/pyrimethamine , sulfadoxine , pregnancy , malaria , pyrimethamine , low birth weight , pediatrics , obstetrics , intensive care medicine , chloroquine , immunology , biology , genetics
Owing to increasing sulfadoxine-pyrimethamine (SP) resistance in sub-Saharan Africa, monitoring the effectiveness of intermittent preventive therapy in pregnancy (IPTp) with SP is crucial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom